Article Information
History
- June 12, 2021.
Article Versions
- You are currently viewing Version 1 of this article (June 12, 2021 - 15:41).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Gil Verschelden1,*,&,
- Maxim Noeparast2,3,*,&,
- Maryam Noparast4,
- Charlotte Michel5,
- Frédéric Cotton6,
- Cleo Goyvaerts7 and
- Maya Hites1,&
- 1Clinic of Infectious Diseases, Cliniques Universitaires de Bruxelles (CUB), Erasme Hospital, Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium
- 2Institute of Molecular Oncology, Member of the German Center for Lung Research (DZL), Philipps University, 35043 Marburg, Germany
- 3Fonds Wetenschappelijk Onderzoek (FWO) – Vlaanderen
- 4Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada
- 5Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles (LHUB-ULB), Brussels, Belgium
- 6Department of Clinical Chemistry, Laboratoire Hospitalier Universitaire de Bruxelles (LHUB-ULB), Université Libre de Bruxelles (ULB), Brussels, Belgium
- 7Laboratory for Molecular and Cellular Therapy (LMCT), Vrije Universiteit Brussel (VUB), 1090 Brussels, Belgium
- ↵&Corresponding authors: Gil.Verschelden{at}erasme.ulb.ac.be, Maxim.Noeparast{at}staff.uni-marburg.de, and Maya.Hites{at}erasme.ulb.ac.be
Posted June 12, 2021.
Plasma zinc status and hyperinflammatory syndrome in hospitalized COVID-19 patients
